Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>FLT3+ *** > Treatment > JP. D. Quizartinib Tablets

---

JP. D. Quizartinib Tablets's subsections
(*) JP Approval Date: 2019. 06.18
(*) USA Approval Date: 2023. 07.20
(*) USA Launch Date: 2023. 08.09
>Companion Diagnostics>
Company
RTM
RTM Web-Site
USA Patent Number

JP. D. Quizartinib Tablets's products
This section has no products